Discover EU-funded research on psilocybin and psilocin: from laboratory mechanisms and clinical programmes to social science. Follow each grant to the European Commission’s CORDIS record, its coordinator and its reported outputs.
Project records describe funded research plans. They are kept separate from publications and clinical-trial registrations; funding does not establish a successful result or an approved treatment.
6 projects in the current snapshot. Last successful CORDIS check: . Automatic checks run daily. Coverage and update method
Find a research project
6 projects in the directory
Ordered by scheduled start, newest first. Country refers to the coordinator; collaborations and research locations may span several countries.
psiloNOVA: the new bridges by psilocybin to treat depression, from gut to brain
Plans to study how psilocybin affects gut–brain signalling, stress regulation, neuroplasticity and immune responses in zebrafish models relevant to depression.
Coordinator and funding
VILNIAUS UNIVERSITETAS Lithuania
Marie Skłodowska-Curie Actions (MSCA) · Horizon Europe EU contribution: €181,136.16
Grant record
Grant agreement: 101277996 Scheduled: – CORDIS status: SIGNED CORDIS record updated: 2026-08-12
Animal-model objectives; this grant record does not establish antidepressant efficacy in people.
Publication search matches the project acronym; matches require source checking and may be absent. CORDIS outputs may include protocols, reviews or other work, rather than trial results.
Preclinical mechanisms · Within scheduled dates
PsyHab
Investigating the effects of psychedelics on Lateral Habenula-Dorsal Raphe Nuclei circuitry in a Lipopolysaccharide model of depression
Investigates how psychedelics affect connections between the lateral habenula and dorsal raphe nuclei in an inflammatory animal model of depression.
Coordinator and funding
NARODNI USTAV DUSEVNIHO ZDRAVI Czechia
Marie Skłodowska-Curie Actions (MSCA) · Horizon Europe EU contribution: €191,918.16
Grant record
Grant agreement: 101210911 Scheduled: – CORDIS status: SIGNED CORDIS record updated: 2026-09-01
Mechanistic animal research; grant dates do not indicate clinical recruitment.
Publication search matches the project acronym; matches require source checking and may be absent. CORDIS outputs may include protocols, reviews or other work, rather than trial results.
Human research and grief · Within scheduled dates
SAIL
The Self After Interpersonal Loss
Studies changes in the sense of self after bereavement and proposes testing whether psilocybin combined with a bodily-self intervention can support adaptation to loss.
Coordinator and funding
LINKOPINGS UNIVERSITET Sweden
European Research Council (ERC) · Horizon Europe EU contribution: €1,491,741.00
Grant record
Grant agreement: 101115653 Scheduled: – CORDIS status: SIGNED CORDIS record updated: 2024-02-06
Research aims are not established treatment effects. Check a trial registry for recruitment and study eligibility.
Publication search matches the project acronym; matches require source checking and may be absent. CORDIS outputs may include protocols, reviews or other work, rather than trial results.
Preclinical mechanisms · Within scheduled dates
FASTer
Identifying the Fast-acting Antidepressant Signatures of Treatment Response with psychedelic compounds using a novel behavioral tracking system and single-cell resolution
Develops behavioural tracking and molecular approaches to investigate the cells and circuits involved in psilocybin-related antidepressant responses in animal research.
Coordinator and funding
KAROLINSKA INSTITUTET Sweden
European Research Council (ERC) · Horizon Europe EU contribution: €1,500,000.00
Grant record
Grant agreement: 101116064 Scheduled: – CORDIS status: SIGNED CORDIS record updated: 2026-03-05
Preclinical methods and objectives do not establish effectiveness in clinical care.
Publication search matches the project acronym; matches require source checking and may be absent. CORDIS outputs may include protocols, reviews or other work, rather than trial results.
Clinical research programme · Within scheduled dates
PsyPal
Psilocybin Therapy for Psychological Distress in Palliative Care Patients
Examines psilocybin therapy for psychological distress in palliative care through a multicentre research programme involving people with serious non-cancer conditions.
Coordinator and funding
ACADEMISCH ZIEKENHUIS GRONINGEN Netherlands
Health · Horizon Europe EU contribution: €6,547,156.75
Grant record
Grant agreement: 101137378 Scheduled: – CORDIS status: SIGNED CORDIS record updated: 2026-03-24
A funded programme is distinct from a trial registration or published results; verify each separately.
Publication search matches the project acronym; matches require source checking and may be absent. CORDIS outputs may include protocols, reviews or other work, rather than trial results.
Social science and policy · Past scheduled end
ReMedPsy
Re-emerging Magic Molecules: The Medicalization of Psychedelics in the United States
Uses qualitative research to examine the medicalisation of psychedelics, including psilocybin, MDMA and ketamine, and the social conditions surrounding renewed research in the United States.
Coordinator and funding
UNIVERSITAT WIEN Austria
EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions · H2020 EU contribution: €261,208.80
Grant record
Grant agreement: 788945 Scheduled: – CORDIS status: CLOSED CORDIS record updated: 2022-08-25
EU funding and an Austrian coordinator do not mean all research activities took place in Europe.
Publication search matches the project acronym; matches require source checking and may be absent. CORDIS outputs may include protocols, reviews or other work, rather than trial results.
Coverage, provenance and automatic updates
This directory uses the European Commission’s public CORDIS data service. Daily checks discover and refresh project records matching psilocybin OR psilocin; a further check requires one of these terms in the project title, objective or keywords. This is a keyword-defined directory, not a complete inventory of European psychedelic research or all European funding sources.
Grant identity, title, coordinator, programme, dates, EU contribution and source-update date come from CORDIS XML. Short research summaries were reviewed on 16 October 2026 and are maintained separately. Newly discovered projects can appear with source metadata before a summary is prepared. Downloads contain grant metadata and the successful source-check timestamp; source objectives and publication abstracts are not redistributed.
The refresh validates every page, the total number of records, project identities and required fields before replacing the snapshot. Failed, incomplete or unexpectedly reduced responses retain the previous complete copy for review. A successful check date means the source was checked, not that every project changed. Sources may lag current project activity.
Scheduled-period labels are calculated from CORDIS start and end dates. They do not establish that a project is running, completed, recruiting or publishing results. EU contribution is the grant amount reported by CORDIS, not verified spending, total project cost or a market valuation.
